Search

everythinglearnresearchcommunity

for

Search:↓

People with alopecia areata often have lower vitamin D levels and more inflammation, suggesting vitamin D might be involved in the condition.

Lower hair zinc and copper levels found in Turkish males with hair loss; higher BMI linked to less hair zinc.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Many young Italian women have hyperandrogenic disorders like PCOS, which are linked to age, body weight, and insulin resistance.

FPHL common in Taiwanese women; risk factors include BMI, high glucose, early puberty, fewer childbirths, oral contraceptives, and UV exposure.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

People with psoriasis are more likely to have Metabolic Syndrome than those without psoriasis.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Daughters of women with PCOS generally experience normal puberty but may have more body hair and different body fat distribution.

The PCOSQ-50 is a valid and reliable questionnaire for measuring quality of life in Iranian women with PCOS.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Balding people may have higher heart disease risk.

Family members of North Indian women with PCOS have a high rate of metabolic syndrome.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

Women with PCOS have higher levels of a certain growth factor, which can be reduced by taking metformin.

Obese women had more testosterone and less acne, but similar hair growth compared to non-obese women.

Indian women with PCOS from Delhi and Srinagar show different symptoms, with Delhi women having higher obesity and blood sugar issues, and Srinagar women showing more hair growth and testosterone levels.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

Oxidative stress, not insulin resistance, is significantly related to free androgen index in PCOS.

Many infertile women with PCOS in Central Vietnam have metabolic or insulin resistance syndrome, with obesity and older age increasing the risk.

Hair loss may indicate higher heart risk and metabolic issues.

Most hirsutism patients had idiopathic hirsutism or PCOS, with hormonal imbalances and signs like acne and irregular periods.

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

The document concludes that the hCG protocol may help in obesity treatment and could be scientifically justified, but more research is needed.

A small number of premenopausal female blood donors had high prolactin levels, often due to stress, and retesting is recommended to prevent misdiagnosis.

Menopause can cause skin issues, and seeing a dermatologist helps.

PCOS is a long-term condition that needs more research for better understanding and treatment.